Caldwell Sutter Capital’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.13K Hold
50
﹤0.01% 793
2026
Q1
$2.41K Hold
50
﹤0.01% 732
2025
Q4
$2.42K Hold
50
﹤0.01% 720
2025
Q3
$2.36K Hold
50
﹤0.01% 721
2025
Q2
$2.42K Sell
50
-50
-50% -$2.56K ﹤0.01% 702
2025
Q1
$5.55K Sell
100
-35
-26% -$1.9K ﹤0.01% 616
2024
Q4
$6.51K Buy
135
+65
+93% +$3.31K ﹤0.01% 604
2024
Q3
$4.03K Hold
70
﹤0.01% 663
2024
Q2
$3.4K Buy
70
+8
+13% +$386 ﹤0.01% 689
2024
Q1
$3.01K Sell
62
-8
-11% -$391 ﹤0.01% 703
2023
Q4
$3.48K Hold
70
﹤0.01% 677
2023
Q3
$3.75K Sell
70
-20
-22% -$1.07K ﹤0.01% 642
2023
Q2
$4.85K Hold
90
﹤0.01% 610
2023
Q1
$4.9K Buy
+90
New +$4.38K ﹤0.01% 441

Other funds holding SNY

Caldwell Sutter Capital's SNY Position: Q2 2026 in Review

Caldwell Sutter Capital held its Sanofi (SNY) position steady in Q2 2026 at 50 shares worth $2.13K. The position accounts for ﹤0.01% of the portfolio, ranked #793.

Caldwell Sutter Capital first reported a position in SNY in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.51K in Q4 2024. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Caldwell Sutter Capital held 50 shares of Sanofi worth $2.13K as of Q2 2026.
  • Caldwell Sutter Capital left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #793 holding.
  • Caldwell Sutter Capital first reported a position in Sanofi in Q1 2023 and has held it in 14 quarters since.
  • Caldwell Sutter Capital's Sanofi position peaked at $6.51K in Q4 2024.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.